PERINATOLOGIYA I PEDIATRIYA PIP_02_2019Scientific and practical journal
INDEXING AND ABSTRACTING
EDITORIAL BOARD AND REVIEW BOARD
OPEN ACCESS POLICY
BIOETHICS, INFORMED CONSENT POLICY AND CONFIDENTIALITY
For all research studies the journal's policy requires an approval of research protocols by an appropriate ethics committee in accordance with international agreements “WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects (last updated: October 2013, Fortaleza, Brazil)” , "Guide for the care and use of laboratory animals (8th edition, 2011)" and/or “International Guiding Principles for Biomedical Research Involving Animals (2012)”.
When reporting research involving human data, authors should indicate whether the procedures were conducted in accordance with bioethical standards and assessed by the local ethics committee or national bioethics commission. The same applies to researcher involving laboratory animals. When reporting experiments on animals, authors should indicate whether all necessary procedures were carried out in accordance with national and international standards for the care and use of laboratory animals.
If the submitted manuscript does not include ethics committee approval, it will be reviewed according to COPE's guideline (Guidance for Editors: Research, Audit and Service Evaluations). If the study should have ethical approval, authors will be asked to provide ethical approval in order to proceed the review process. If they cannot provide ethical approval, their manuscript will be rejected.
If the study does not need ethics committee approval after the editorial board’s review, the authors will be asked to provide an ethics committee approval or a document given by a related independent committee that indicates the study does not need ethics committee approval according to the research integrity rules in their country. If the authors provide either an approval or a document showing that ethics approval is not needed, the review process can be continued. If the authors cannot provide either documents, the manuscript may be rejected.
Approval by a local ethics committee does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.
For articles concerning experimental research on humans, a statement should be included that shows informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo. The journal may request a copy of the Ethics Committee Approval received from the relevant authority. Informed consent must also be obtained for case reports.
Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication.
Patient consent should be written and archived with the authors at the institution where research was conducted. The authors provide the journal with a written statement that attests that they have received and archived written patient consent. The requirement for informed consent should be included in the journal's instructions for authors. When informed consent has been obtained it should be indicated in the published article.
The manuscript must include in the section “Materials and methods” a statement identifying the institutional local ethics committee approving the experiments, including any relevant details For experiments involving human subjects, authors must identify the local ethics committee approving the experiments, and include with their submission a statement confirming that informed consent was obtained from all subjects.
REVIEW PROCESS, INSTRUCTIONS FOR REVIEWERS
Criteria for publication
Journal receives many more submissions than it can publish in each edition. It is therefore important that manuscripts are critically evaluated for compliance with the following criteria:
- Strong evidence for the conclusions that are drawn
- Novelty (abstracts, meeting proceedings, preprints are not considered to compromise novelty)
- Broad clinical significance
- Importance to the specific field
Once a manuscript is submitted for publication as a hard copy by mail, it is registered (date of registration) and is subject to double blind peer review, neither the authors nor the reviewers do not know each other. All submitted manuscripts are assessed by the editor(s) for suitability for the review process. The average time of the reviewing process is 4 – 6 months.
Manuscripts that are sent for formal review typically go to 2 referees who are appointed by the editorial board. The referees are asked for their opinion about the suitability of the paper for publication. Based on their advice, the editor decides to:
– accept the manuscript, with or without minor revision
– invite the authors to revise the manuscript to address specific concerns before a final decision is reached
– or reject the manuscript, typically on grounds of specialist interest, lack of novelty, insufficient conceptual advance or major technical and/or interpretational problems.
The result of the review is based on the offered recommendations of the reviewers and decision of the editor on publication of the article is final. In the case of a positive result of the review, the manuscript is sent to the editor for further processing and publication. If necessary, the manuscript is sent to the author for revision in accordance with the recommendations of the reviewer(s). Revised manuscript sent for re-review. In the case of the negative results of the review, the author receives the information that the article is not accepted for publication with motivated refusal. The manuscript is not returned to the author.
Journal editors treat the submitted manuscript and all communication with authors and referees as confidential. Authors must also treat communication with the journal as confidential: correspondence with the journal, reviewers' reports and other confidential material must not be posted on any website or otherwise publicised without prior permission from the editors, whether or not the submission is eventually published.
Referee selection is critical to the review process, and our choice is based on many factors, including expertise, reputation, specific recommendations, and our previous experience with the referee. We avoid using referees who are chronically slow, sloppy, too harsh or too lenient. We invite referees and only on acceptance of the invitation will a referee have access to the full paper.
Upon receiving a manuscript to referee
To avoid unnecessary delays in processing manuscripts, please do the following immediately upon receipt of a manuscript for review:
- check thoroughly the deadline to ensure that there have been no misunderstandings
- in regarding to timing, contact the editorial office immediately if you anticipate any difficulties
- read the editor's letter carefully and be sure to note any points specific to the manuscript that the editor may have requested your opinion on
- skim the manuscript and consider whether there might be a conflict of interest for you (with the authors, their institution, their funding sources) and whether you can judge the article impartially
- consider whether the topic seems to fit the scope of the journal and is likely to be of sufficient general interest for publication.
Referees should treat the review process as being strictly confidential, and should keep the following guidelines in mind:
– refereed manuscripts for the Journal should not be discussed with anyone not directly involved in the review process
– if colleagues or experts are consulted, they should be identified to the editors
– referees should, as a rule, not disclose their identities to the authors or to other colleagues since they may be asked to comment on the criticisms of other referees and may then find it difficult to be objective. Should they feel strongly about making their identities known to the authors, they should do so via the editor. We strongly disapprove of any attempt by authors to determine the identities of referees or to confront them, and encourage referees to neither confirm nor deny any speculation in this regard.
Writing the report
The main purpose of referee reports is to provide the editors with the information that they need to reach a decision, but they should also instruct the authors on how to strengthen their manuscript if revision is a possibility. Referees are asked to submit both confidential comments to the editor and those that can be directly transmitted to the authors. We recommend the following division of the report:
While transmitting comments to the authors, referees are asked to maintain a positive and impartial, but critical, attitude in evaluating manuscripts. Criticisms should remain dispassionate; offensive language is not acceptable. As far as possible, a negative report should explain to the authors the weaknesses of their manuscript, so that they can understand the basis for a decision to ask for revision or to reject the manuscript. The report for authors should not include a recommendation regarding publication, which is regarded as confidential information since the final decision regarding acceptance, revision or rejection rests with the editor.
The Journal is committed to rapid editorial decisions and publication as efficiency in this process is a valuable service both to our authors and the scientific community as a whole. We therefore ask that referees respond promptly or inform us if they anticipate a significant delay, which allows us to keep the authors informed and, where necessary, find alternative referees.
Conflicts of interest
In order to ensure fairness in the referee process, we try to avoid referees who: have recent or ongoing collaborations with the authors, have commented on drafts of the manuscript, are in direct competition, have a history of dispute with the authors, or have a financial interest in the outcome. Because it is not possible for the editors to know of all possible biases, however, we ask referees to draw our attention to anything that might affect their report, including commercial interests, and to decline to referee in cases where they feel unable to be objective. We do not find it necessary to exclude referees who have reviewed a paper for another journal; the fact that two journals have independently identified a particular person as well qualified to referee a paper does not decrease the validity of her/his opinion in our view.
Publication policy and ethical considerations
In spite of the journal best efforts to identify breaches of publication policy or ethical conduct, such as plagiarism or author conflict of interest, the referees who are more familiar with the field are more likely to recognise such problems and should alert the editors to any potential problems in this regard.
These guidelines complies with the requirements of the International Committee of Medical Journal Editors (ICMJE) that review best practice and ethical standards in the conduct and reporting of research and other material published in medical journals.
The journal considers manuscripts in the following categories: reports of original research, review articles, case reports, editorials, reviewer commentaries, etc. While preparing a manuscript for journal, authors should determine the manuscript type and then prepare manuscript according to the specific instructions presented below.
The manuscript should be typed in a Microsoft Word file, single-column format, 1.5-spaced with 2.5 cm margins on left side, 1.0 cm – right side, up and down – 2.0 cm and 12-point type in Times New Roman font. Decimal points should be used in decimals throughout the manuscript. Measurements should be reported using the metric system according to the International System of Units (SI). Illustrations (tables, figures) should be titled, sequentially numbered and presented within the relevant places of the manuscript, and refered to the text.
All abbreviations in the text must be defined the first time they are used (both in the abstract and the main text), and the abbreviations should be displayed in parentheses after the definition. Authors should avoid abbreviations in the title and abstract and limit their use in the main text.
Manuscripts for publication are accepted either in Ukrainian, Russian or English languages from any country. Abstracts are published in three languages (Ukrainian, Russian and English). The journal does not provide translation and editing articles in English; low-quality written articles in English are not published. The English article submitted by foreign and Ukrainian authors are published without translation in Ukrainian.
Identification of article type is the first step of manuscript submission because article type dictates the guidelines that should be used (see below), including formatting and page limits of the manuscript. The main categories of article type are outlined below:
Original articles contains substantial novel research. These articles can include randomized controlled trials, observational (cohort, case-control or cross-sectional) studies, diagnostic accuracy studies, systematic reviews and meta-analyses, nonrandomized behavioral and public health intervention trials. Manuscript of the original article consists of follow sections: title page, main text, abstracts with key words (Ukrainian, Russian, English), additional information, references.
Title (first) page indicates (up down) Universal Decimal Classification (UDC), article title (capital letters), author names (initials and family name), institutional name, city, country.
The main text should be structured with the following subheadings: introduction (wider context that generated the study and the hypothesis based on the literature datа no older than 5-7 years), objective, materials and methods, results and discussions (presenting the data in text, tables and figures with statistical analysis, interpretation and significance of the findings), conclusions with indications of the future research direction, acknowledgements, conflict of interest, references. The main text should not exceed 8 pages, excluding the abstract, references, tables, and figure legends. There should be a maximum of 30 references.
Last page must contain signatures of all authors, full author’s names, their scientific degree and titles, job position, full institutional mailing addresses, numbers of telephones, ORCID ID, scientific contributions and responsibilities of all authors. Must be indicated the contact person (responding author).
Authors are responsible for the accuracy of references. Only papers directly related to the article should be cited. Citations should be numbered in alphabetical order. Papers in press and papers already submitted for publication may be included in the list of references but no citation is required for work that is not yet submitted for publication.
Abstracts should not exceed 250 words and should be structured with the following subheadings: background, objective, materials and methods, results, conclusions and key words. All titles of headings should be highlighted. The manuscript should contain the abstracts in Ukrainian, Russian and English, self-contained and citation-free. At the end of the abstract, the key words are listed.
Review Article is a comprehensive analysis of specific topics in medicine, which is written by author (s) with extensive experience and publications on the review subjects. All review articles will also undergo peer review prior to acceptance. Review articles must not exceed 12 pages for the main text (excluding references, tables, and figure legends) and 400 words for the abstract. A review article can be signed by no more than 5 authors and can have no more than 50 references.
Case report represents interesting rare cases containing a substantial novel finding. Cases should be unique, representing a diagnostic or therapeutic challenge and having a learning point for the readers. Abstracts of case reports should mainly include information about the case and should be lim ited to a maximum of 250 words. The abstract must begin on a separate page and should be structured with the following subheadings: background, case report and conclusion. The main text of case reports should be structured with the following subheadings: introduction, case report, discussion, and references. Case reports must not exceed 7 pages (excluding references, tables, and figure legends). Case reports can be signed by no more than 5 authors and can have no more than 10 references and 5 figures or tables.
Letter to the Editor must not exceed 7 pages (excluding references). An abstract is not required with this type of manuscripts. A letter can be signed by no more than 4 authors and can have no more than 5 references and 1 figure or table.
Other. Editorials, reviewer commentaries, book reviews, and reports on publication and research ethics are requested by the Editorial Board.
Submission of a manuscript
The manuscript is submitted for publication as a hard copy by mail or via electronic mail firstname.lastname@example.org. The manuscript must be accompanied with the official (cover) letter from the institution where the research was carried out, singed by institutional authorities (research advisor) and sealed, and expert conclusion (publishing expert committee) indicating the possibility for publishing.
Cover letter. The cover letter should include the article title and the full name of the author(s). The in the content of the letter author(s) should briefly summarize why submitted article paper is a valuable addition to the scientific literature and specify the type of article (for example, original article, case report, review article, etc.). The cover letter should also include a statement declaring the absence or presence of a conflict of interest, research studies and preparation of the manuscript were done in accordance with standards of research and publication ethics. Furthermore, there should be a statement that the manuscript has not already been published, accepted or under simultaneous review for publication elsewhere. The journal does not accept multiple submission and duplicate submission even though the previous one was published in a different language.
Expert institutional conclusion for publishing. Each institution where research studies are conducted has expert committee. The main aim of the expert committee is to provide pre-publish review of articles (publishing and ethical standards, approval of institutional ethic committee, confidentiality, innovation of article reports, conflict of interest, etc.). The result of this review is an approval for possibility of publication which is submitted with the cover letter and manuscript.
Components of manuscript
Please note that original articles must contain the following components. Please see below for further details
Title page. Manuscript shoud be numbered from the first to the last page and signed by all authors (including tables and figures). The first page indicates Universal Decimal Classification (UDC), paper title (capital letters), author names (initials and family name), institutional name, city, country.
The title should be brief and informative, of 150 characters or less, convey the essential message of the paper and contain no abbreviations. On the top of the page left side should be posted the signature of institutional authorities (research advisor) certified by the institutional seal.
Abstracts. Original articles, review articles and case reports should include an abstract. The abstract should be written in Ukrainian, English and Russian languages. Abstracts for original articles should be structured with the following subheadings: background, objective, materials and methods, results, conclusions and key words. Abstracts for case reports should be structured with the following subheadings: background, case report, and conclusion. Abstracts for review articles should not be structured. Editorials, letters to the Editor, and commentaries should not contain an abstract.
Introduction. The Introduction should assume that the reader is knowledgeable in the field and should therefore be as brief as possible, but can include a short historical review where desirable. The relevance и significance of the research are highlighted, the goals and objectives of the studies are justified. The introduction is outlining the wider context that generated the study and the hypothesis. Introduction may contain 10-15 references to scientific periodicals which were published for the last 5–7 years.
Materials and methods. This section should contain sufficient detail, so that all experimental procedures can be reproduced, and include references. Methods, however, that have been published in detail elsewhere should not be described in detail. Authors should provide the name of the manufacturer and their location for any specifically named medical equipment and instruments, and all drugs should be identified by their pharmaceutical names, and by their trade name if relevant.
When reporting research involving human data, authors should indicate whether the procedures were conducted in accordance with bioethical standards and assessed by the local ethics committee or national bioethics commission. The same applies to researcher involving laboratory animals. When reporting experiments on animals, authors should indicate whether all necessary procedures were carried out in accordance with national and international standards for the care and use of laboratory animals. All procedures should be described in this section.
For example: "The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee (LEC) or National Bioethics Committee of all participating institution”, «When carrying out experiments with laboratory animals, all bioethical norms and recommendations were observed»
For articles concerning experimental research on humans, a statement should be included that shows informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo.
For example: “The informed consent of the patient was obtained for conducting the studies".
Conclusions. The final paragraph should highlight the main conclusion(s), and provide some indication of the direction future research should take.
Acknowledgements. The authors may express their gratitude to the people and organizations contributed to the article to be published in the journal, but not being the authors. Should include sources of support including sponsorship (e.g. university, charity, commercial organization) and sources of material (e.g. novel drugs) not available commercially.
Conflict of Interest. Authors must declare whether or not there are any competing financial interests in relation to the work described. This information must be included at this stage and will be published as part of the paper. Conflict of interest should also be noted on the cover letter and as part of the submission process. Declaration of the conflict of interest is obligatory
Example: “The authors declare they have no conflict of interest”
References. Authors are encouraged to cite primary literature rather than review articles in order to give credit to those who have performed the original work. Reference listings must be in accordance with ICMJE standards and numbered at the end of the manuscript in the alphabetic order. While citing publications, preference should be given to the latest, most up to date publications. Authors are responsible for the accuracy of references. In the main text of the manuscript, references should be cited using Arabic numbers in square brackets. The reference style of publications are presented in the following example:
Reference to an article from journal:
Author AA, Author BB, Author CC. (2005). Title of the article. Title of Journal. 10(2);3:49-53.
Reference to a book:
Author AA, Author BB, Author CC. (2006). Titile of the book. Kyiv: MedEspert: 256.
Tables. The tables must have the heading and the serial number. The notes on the table are placed straight under the table. All tables should be referred to within the main text and they should be numbered consecutively in the order they are referred to within the main text. A descriptive title should be provided for all tables and the titles should be placed above the tables. Tables should be presented within the main document after the reference list. Reference to table footnotes should be made by means of Arabic numerals. Tables should not duplicate the content of the text. They should consist of at least two columns; columns should always have headings. Authors should ensure that the data in the tables are consistent with those cited in the relevant places in the text, totals add up correctly, and percentages have been calculated correctly. Unlike figures or images, tables may be embedded into the word processing software if necessary, or supplied as separate electronic files.
Figures. The number of illustrations (figures, diagrams, Ысуьы ) should be minimal. Illustrations (graphics, figures and schemes) are built in Word or Excel programs, photos should be saved in one of the following formats: PDF, TIFF, PSD, EPS, AI, CDR, QXD, INDD, JPG (150-600 dpi). Tables and figures are placed in the text of the article immediately after the first mentioned. In the caption to the figure its name is given, and explanation of all the conventional symbols (numbers, letters, curves, etc.). Tables should be compact, numbered, and named. The table numbers, their headings and digital data processed statistically must exactly match the ones given in the text
DISTRIBUTION & SUBSCRIPTION
INFORMATION FOR ADVERTISERS
Concerning accommodation of an advertising please contact to the publishing house : +38 044 498 08 80 (34) Irina Arestovich
Group of companies «MedExpert»
Address for correspondence: 04211, Ukraine, Kyiv, Kruglouniversitetska, 2/1, office 18
Tel/fax: +38 044 498 0834; +38 044 498 0880.
E-mail: email@example.com; firstname.lastname@example.org